Jazz Pharmaceuticals plc
JAZZ
$181.37
-$0.65-0.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.08% | 134.99% | -676.38% | -148.42% | -11.13% |
| Total Depreciation and Amortization | 0.52% | 2.43% | 5.54% | -2.10% | 1.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 161.28% | -108.94% | 1,280.96% | -41.55% | 165.33% |
| Change in Net Operating Assets | -155.59% | 140.00% | -213.62% | 460.19% | -202.98% |
| Cash from Operations | -23.62% | 434.15% | -79.33% | 7.83% | -0.04% |
| Capital Expenditure | -10.24% | -17.03% | 6.58% | -4.47% | -23.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.70% | -235.92% | 248.34% | 13.86% | -180.04% |
| Cash from Investing | -13.53% | 48.86% | -279.46% | 12.60% | -190.28% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 0.00% | 0.00% | 98.98% | -9,677.42% | 98.67% |
| Issuance of Common Stock | 11,521.56% | -93.02% | -8.30% | 24.48% | 53,994.12% |
| Repurchase of Common Stock | 47.64% | 97.00% | -89.50% | -1,576.98% | 97.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 796.65% | 91.30% | 84.69% | -9,730.40% | -103.36% |
| Foreign Exchange rate Adjustments | -83.74% | -95.61% | 172.80% | 174.05% | -174.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.66% | 120.26% | -21.99% | -382.92% | -77.42% |